首页> Oral oncology> Establishing M1 subdivision for de novo nasopharyngeal carcinoma patients receiving immuno-chemotherapy: A multicenter, retrospective cohort study.

Establishing M1 subdivision for de novo nasopharyngeal carcinoma patients receiving immuno-chemotherapy: A multicenter, retrospective cohort study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Shui-Qing,He

第一单位： Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060 Guangzhou, China.

作者： Shui-Qing,He ^[1] ; Guo-Ying,Liu ^[2] ; Ya-Hui,Yu ^[3] ; Lin,Wang ^[1] ; Guo-Yi,Zhang ^[4] ; Ding-Sheng,Peng ^[5] ; Wei-Xin,Bei ^[1] ; Chun-Lan,Chen ^[4] ; Shu-Hui,Lv ^[1] ; Ze-Yu,Zhao ^[1] ; Ying,Huang ^[6] ; Yan-Qun,Xiang ^[7]

作者单位： Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060 Guangzhou, China. ^[1] Department of Oncology, Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. ^[2] Department of Radiation Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China. ^[3] Department of Radiation Oncology, Cancer Center, the First People's Hospital of Foshan, Foshan 528000, Guangdong, China. ^[4] Department of Radiation Oncology, Huizhou Central People's Hospital, No. 41, Eling North Road, Huicheng District, Huizhou 516008, China. ^[5] Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060 Guangzhou, China. Electronic address: huangying@sysucc.org.cn. ^[6] Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 510060 Guangzhou, China. Electronic address: xiangyq@sysucc.org.cn. ^[7]

关键词 De novo nasopharyngeal carcinoma Immunotherapy Prognosis RPA Stage